BioNexus Gene Lab to Establish Ethereum Reserve
The board of directors of Nasdaq-listed technology firm BioNexus Gene Lab (BGLC) has approved the addition of Ethereum as a strategic treasury asset. In the presented Ethereum Strategy Whitepaper, the management justified their choice with the following factors: institutional reliability: adoption among financial institutions and ETFs; yield generation opportunities: Proof-of-Stake; dominance in financial infrastructure: “trillions […]